| | Trinseo PLC Suite 301 Wayne, PA 19087 |
| | |
June 12, 2024
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, NE
Washington, DC 20549
Attention: | Jeanne Baker |
| Nudrat Salik |
| |
RE: | Trinseo PLC |
| Comment Letter Dated June 7, 2024 |
| Form 10-K for the Year Ended December 31, 2023 |
| File No. 001-36473 |
To the Staff of the Division of Corporate Finance:
Below please find the responses (the “Responses”) of Trinseo PLC (“Trinseo” or together with its subsidiaries, the “Company”) to the comment (the “Comment”) set forth in the letter dated June 7, 2024 from the staff of the Division of Corporate Finance (the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) to Trinseo.
For the convenience of the Staff, we have restated the Comment in bold in this letter, and the corresponding responses of the Company are shown below such Comment. References to page numbers are to the page numbers in the corresponding filings.
Form 10-K for the Year Ended December 31, 2023
Financial Statements, page F-1
1. | We note your response to comment 1. Please provide us with the calculations and corresponding explanations which led to your determination that Americas Styrenics LLC was not significant in any period presented pursuant to Rule 3-09 and Rule 1-02(w) of Regulation S-X. |
Response:
The Company acknowledges the Staff’s Comment and respectfully submits the following calculations for all periods presented in the Company’s financial statements for the year ended December 31, 2023, along with the calculation for the year ended December 31, 2020 (the last year Americas Styrenics LLC met the definition of “significant subsidiary” under the investment test or income test according to Rule 1-02(w) of Regulation S-X required under Rule 3-09 of Regulation S-X).
On an annual basis, the Company performs the significant subsidiary tests required by Rule 3-09 of Regulation S-X for its 50 percent or less owned subsidiary accounted for under the equity method to determine whether separate financial statements of the subsidiary will need to be filed.
Investment Test
For the investment test, according to Rule 1-02(w)(1)(i)(A) of Regulation S-X, the test is only met when the investment in and any advances to Americas Styrenics LLC exceed 20% of the Company’s consolidated assets in the Company’s consolidated financial statements for any period presented.
| Fiscal Year 2020 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2023 | |||||
Numerator – carrying value of investment | 240.1 | 247.8 | 255.1 | 252.2 | |||||
Denominator – Company’s total assets | 2,845.2 | 4,712.2 | 3,760.2 | 3,029.2 | |||||
Investment Test Calculation | 8.44% | 5.26% | 6.78% | 8.33% | |||||
Significant Subsidiary Conclusion | No | No | No | No | |||||
Income Test
For the income test, according to Rule 1-02(w)(1)(iii)(A) of Regulation S-X, the test is only met when both (1) earnings before taxes attributable to the Company and (2) proportionate share of the total revenue of Americas Styrenics LLC exceed 20% of such amounts in the Company’s consolidated financial statements for any period presented.
Income Test 1 – income | Fiscal Year 2020 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2023 | ||||
Numerator – | | | | | ||||
Proportionate share of Americas Styrenics earnings before taxes | 42.7 | 102.3 | 106.1 | 67.8 | ||||
Adjustments to Numerator 1 | 26.6 | (6.6) | 0.2 | (3.9) | ||||
Adjusted Numerator | 69.3 | 95.7 | 106.3 | 63.9 | ||||
| | | | | ||||
Denominator – | | | | | ||||
Income (loss) from continuing operations before income taxes of the Company | 105.4 | 350.5 | (469.6) | (632.9) | ||||
less Equity in earnings of unconsolidated affiliate | N/A2 | N/A2 | 102.2 | 62.1 | ||||
Absolute value | 105.4 | 350.5 | 571.8 | 695.0 | ||||
Income Test 1 Calculation | 65.75% | 27.30% | 18.59% | 9.19% | ||||
| 1. | Items impacting net income of the registrant that should be excluded from the numerator of the income test include (but are not necessarily limited to) impairment charges recorded at the investor level, gains or losses from stock sales by the investor, dilution gains/losses from stock sales by the investee, the investor's share of accounting changes reported in the financial statements of the investee and preferred dividends. |
| a. | Therefore, in the Income Test above, all numerator balances are the Company’s proportionate share of the “Pre-Tax Income” of Americas Styrenics, adjusted for the Company’s accounting policy specific to treatment of costs related to planned major maintenance activities (Americas Styrenics accounts for these costs in the P&L whereas the Company capitalizes these costs & depreciates them over the respective period (i.e. until the next major maintenance project)). |
| 2. | Equity earnings are not subtracted from the Company’s income from continuing operations during periods where both entities had income. |
Income Test 2 – revenue | Fiscal Year 2020 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2023 |
Numerator – proportionate share of Americas Styrenics Total Revenue | 557.8 | 911.1 | 1,030.0 | 861.2 |
Denominator – Continuing Operations Sales of the Company | 2,744.6 | 4,827.5 | 4,965.5 | 3,675.4 |
Income Test 2 Calculation | 20.32% | 18.87% | 20.74% | 23.43% |
| | | | |
Meet Significance (>20%) under both the income and the revenue test? | Yes | No | No | No |
In performing both the investment and the income test, detailed above, the Company noted in its Form 10-K for the year ended December 31, 2023, that both criteria were not met for each of the years presented. Therefore, inclusion of the financial statements of Americas Styrenics LLC is not required pursuant to Rule 3-09 of Regulation S-X, and the Company provided summarized financial information in the footnotes to its Form 10-K (Footnote 13 – Investments in Unconsolidated Affiliates, pages F-30 and F-31).
| Fiscal Year 2020 | Fiscal Year 2021 | Fiscal Year 2022 | Fiscal Year 2023 |
Investment Test Conclusion | No | No | No | No |
Income Test Conclusion | Yes | No | No | No |
Significant Subsidiary Conclusion | Yes | No | No | No |
I hope that the foregoing has been responsive to your comments. If you should have any questions about this letter or require any further information, please contact the undersigned at (610) 240-3200. Thank you for your assistance.
| Very truly yours, | |
| | |
| | /s/ David Stasse |
| | David Stasse |
| | Executive Vice President and Chief Financial Officer |
| | 400 E. Swedesford Rd. |
| | Suite 301 |
| | Wayne, PA 19087 |
| | |
cc:Frank Bozich, Chief Executive Officer and President
Angelo N. Chaclas, Chief Legal Officer, Senior Vice President and Corporate Secretary